デフォルト表紙
市場調査レポート
商品コード
1559108

慢性閉塞性肺疾患(COPD)および喘息用デバイスの世界市場レポート 2024年

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.05円
慢性閉塞性肺疾患(COPD)および喘息用デバイスの世界市場レポート 2024年
出版日: 2024年09月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

慢性閉塞性肺疾患(COPD)および喘息用デバイスの市場規模は、今後数年間で力強い成長が見込まれます。2028年の年間平均成長率(CAGR)は6.2%で、570億8,000万米ドルに成長します。予測期間中に予想される成長は、呼吸器疾患の有病率の上昇、タバコ喫煙の増加、環境汚染レベルの上昇とそれに関連する呼吸問題、ヘルスケア支出の増加、ドラッグデリバリー機器の携帯性向上などからもたらされるとみられます。この期間に予想される主な動向には、技術の進歩、スマート技術の統合、個別化医療、生物製剤の採用、ウェアラブル呼吸器モニターの使用などがあります。

呼吸器疾患の罹患率の増加が慢性閉塞性肺疾患(COPD)および喘息用デバイス市場の拡大を牽引すると予測されます。呼吸器疾患には、喘息、COPD、肺炎、肺がんなど、肺や呼吸器系に影響を及ぼすさまざまな疾患が含まれ、呼吸や呼吸器機能全体に影響を及ぼします。これらの疾患の有病率の上昇は、大気汚染の深刻化、アレルゲンや病原体に影響を与える気候変動、呼吸器の健康を損なう喫煙などのライフスタイルの選択などの要因に関連しています。COPDと喘息用に設計されたデバイスは、これらの疾患の効果的な管理と治療に不可欠であり、患者が呼吸器系の健康を改善し、全体的な幸福感を向上させるのに役立っています。例えば、世界保健機関(WHO)が2023年3月に報告したように、COPDは世界第3位の死因であり、約323万人の死亡を占め、その90%近くが低・中所得国(LMICs)の70歳未満で発生しています。このような呼吸器疾患の有病率の上昇が、COPDおよび喘息機器市場の成長を促進しています。

慢性閉塞性肺疾患(COPD)および喘息用デバイス市場の主要企業は、遠隔モニタリングや個別化治療のためのデジタルヘルス機能を統合した吸入機器などの革新的技術の創出に注力しています。吸入デバイスは、吸入によって肺に直接薬剤を送達するために使用されます。例えば、2022年5月、インドの製薬会社であるAlkem Laboratories社は、喘息やCOPDの人々の生活を改善するために設計されたドライパウダー吸入器(DPI)であるInnohalerを発売しました。Innohalerは、高度な呼吸作動技術を採用し、吸入ごとに正確な薬物送達を行うことで、投与量の精度を高め、無駄を最小限に抑えます。人間工学に基づいたデザインで、あらゆる年齢の患者に適した使いやすいインターフェースを備えています。さらに、コンパクトで持ち運びやすいデザインは、外出先での利便性を高め、治療計画の遵守をサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場の実績:規模と成長, 2018-2023
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 定量吸入器
  • 薬剤粉末吸入器
  • ソフトミスト吸入器
  • ジェットネブライザー
  • 超音波ネブライザー
  • その他のタイプ
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 喘息
  • 慢性閉塞性肺疾患
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院
  • クリニック
  • 在宅ケア環境
  • 調査機関
  • その他のアプリケーション
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 小児
  • 成人
  • 高齢者

第7章 地域別・国別分析

  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:競合情勢
  • 慢性閉塞性肺疾患(COPD)および喘息用デバイス市場:企業プロファイル
    • AstraZeneca Plc
    • Novartis AG
    • GlaxoSmithKline Plc
    • 3M Health Care
    • Boehringer Ingelheim

第31章 その他の大手企業と革新的企業

  • Royal Philips NV
  • Teva Pharmaceuticals Industries Ltd.
  • Baxter International Inc.
  • Omron Corporation
  • Smiths Medical Inc.
  • Recipharm AB
  • Cipla Ltd.
  • Teleflex Incorporated
  • Chiesi Farmaceutici SpA
  • Lincre Holdings Inc.
  • Sunovion Pharmaceuticals Inc.
  • Verona Pharma plc
  • Drive DeVilbiss Healthcare
  • Pari Respiratory Equipment Inc.
  • Allied Healthcare Products Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r19612

Devices for chronic obstructive pulmonary disease (COPD) and asthma are medical tools designed to manage and treat breathing and respiratory issues. These devices assist patients in breathing more efficiently, controlling symptoms, and enhancing their overall quality of life.

Key types of these devices include metered dose inhalers, dry powder inhalers, soft mist inhalers, jet nebulizers, ultrasonic nebulizers, and others. Metered Dose Inhalers are portable devices that administer medication in a precise spray or mist, commonly used for conditions such as COPD and asthma by delivering the medication directly into the lungs. They are small and easy to carry, making them suitable for everyday use. These devices are utilized in various settings such as hospitals, clinics, home care, and research facilities, and cater to different age groups including pediatric, adult, and geriatric patients.

The chronic obstructive pulmonary disease (COPD) and asthma devices market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease (COPD) and asthma devices market statistics, including chronic obstructive pulmonary disease (COPD) and asthma devices industry global market size, regional shares, competitors with an chronic obstructive pulmonary disease (COPD) and asthma devices market share, detailed chronic obstructive pulmonary disease (COPD) and asthma devices market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease (COPD) and asthma devices industry. This chronic obstructive pulmonary disease (COPD) and asthma devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $42.49 billion in 2023 to $44.95 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The increase observed during the historical period can be ascribed to several factors, including the expanding elderly population, a higher incidence of allergies, more government initiatives, a rise in clinical research and trials, and increasing urbanization.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $57.08 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period is expected to stem from the rising prevalence of respiratory diseases, increased cigarette smoking, elevated environmental pollution levels and related breathing issues, greater healthcare spending, and enhanced portability of drug delivery devices. Key trends anticipated for this period include advancements in technology, the integration of smart technology, personalized medicine, the adoption of biologics, and the use of wearable respiratory monitors.

The increasing incidence of respiratory diseases is anticipated to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market. Respiratory diseases include various conditions that affect the lungs and respiratory system, such as asthma, COPD, pneumonia, and lung cancer, which impact breathing and overall respiratory function. The rising prevalence of these diseases is linked to factors such as escalating air pollution, climate changes that influence allergens and pathogens, and lifestyle choices such as smoking that impair respiratory health. Devices designed for COPD and asthma are essential for effective management and treatment of these conditions, helping patients achieve better respiratory health and improved overall well-being. For example, as reported by the World Health Organization (WHO) in March 2023, COPD was the third leading cause of death worldwide, accounting for about 3.23 million deaths, with nearly 90% of these fatalities occurring in low- and middle-income countries (LMICs) among individuals under 70 years old. This rising prevalence of respiratory diseases is fueling growth in the COPD and asthma devices market.

Leading companies in the COPD and asthma devices market are concentrating on creating innovative technologies, such as inhalation devices with integrated digital health features for remote monitoring and personalized treatment. Inhalation devices are used to deliver medication directly to the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an Indian pharmaceutical company, launched the Innohaler, a dry powder inhaler (DPI) designed to improve the lives of people with asthma and COPD. The Innohaler features advanced breath-actuated technology for accurate medication delivery with each inhalation, enhancing dosage precision and minimizing waste. Its ergonomic design makes it easy to use, with a user-friendly interface suitable for patients of all ages. Additionally, its compact and portable design increases convenience for use on the go, supporting better adherence to treatment regimens.

In March 2022, Philip Morris International Inc., a US-based tobacco company, acquired Vectura Group plc. for an undisclosed amount. This acquisition is aimed at utilizing Vectura's expertise in inhalation technology to advance the development of reduced-risk products (RRPs) and other non-combustible alternatives. Vectura Group plc, a UK-based pharmaceutical company, specializes in inhaled medicines and inhaler devices for treating respiratory diseases such as asthma and COPD.

Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic obstructive pulmonary disease (COPD) and asthma devices market consists of sales of spacer devices, peak flow meters, oxygen therapy equipment, pulse oximeters, and airway clearance devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic obstructive pulmonary disease (COPD) and asthma devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic obstructive pulmonary disease (COPD) and asthma devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic obstructive pulmonary disease (COPD) and asthma devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Metered Dose Inhalers; Drug Powder Inhalers; Soft Mist Inhalers; Jet Nebulizers; Ultrasonic Nebulizers; Other Types
  • 2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease
  • 3) By Application: Hospitals; Clinics; Home Care Settings; Research Institutions; Other Applications
  • 4) By End User: Pediatric; Adult; Geriatric
  • Companies Mentioned: AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc; 3M Health Care; Boehringer Ingelheim
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Characteristics

3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends And Strategies

4. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size and Growth

  • 5.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segmentation

  • 6.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metered Dose Inhalers
  • Drug Powder Inhalers
  • Soft Mist Inhalers
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Other Types
  • 6.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • 6.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Care Settings
  • Research Institutions
  • Other Applications
  • 6.4. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pediatric
  • Adult
  • Geriatric

7. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Regional And Country Analysis

  • 7.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 8.1. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 9.1. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 9.2. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 10.1. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 11.1. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 11.2. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 12.1. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 13.1. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 14.1. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 14.2. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 15.1. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 15.2. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 16.1. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 17.1. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 18.1. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 19.1. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 20.1. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 21.1. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 21.2. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 22.1. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 23.1. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 23.2. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 24.1. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 24.2. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 25.1. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 25.2. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 26.1. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 26.2. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 27.1. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 28.1. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 28.2. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

  • 29.1. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
  • 29.2. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape And Company Profiles

  • 30.1. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape
  • 30.2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Company Profiles
    • 30.2.1. AstraZeneca Plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GlaxoSmithKline Plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. 3M Health Care
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boehringer Ingelheim
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Other Major And Innovative Companies

  • 31.1. Royal Philips NV
  • 31.2. Teva Pharmaceuticals Industries Ltd.
  • 31.3. Baxter International Inc.
  • 31.4. Omron Corporation
  • 31.5. Smiths Medical Inc.
  • 31.6. Recipharm AB
  • 31.7. Cipla Ltd.
  • 31.8. Teleflex Incorporated
  • 31.9. Chiesi Farmaceutici SpA
  • 31.10. Lincre Holdings Inc.
  • 31.11. Sunovion Pharmaceuticals Inc.
  • 31.12. Verona Pharma plc
  • 31.13. Drive DeVilbiss Healthcare
  • 31.14. Pari Respiratory Equipment Inc.
  • 31.15. Allied Healthcare Products Inc.

32. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking

33. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Future Outlook and Potential Analysis

  • 35.1 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer